Skip to main content
Professional Technical IVT

Atypia of Undetermined Significance

Also written as: AUS — Atypia of Undetermined Significance

A Bethesda Category III cytological diagnosis indicating cellular abnormalities that cannot be definitively classified as benign or malignant.

Full Definition

Atypia of undetermined significance (AUS) is a diagnostic category in the Bethesda System representing thyroid FNA samples with cytological features that are neither clearly benign nor definitively suspicious for malignancy. This category encompasses cases with architectural atypia, nuclear atypia insufficient for a suspicious diagnosis, or follicular lesions with nuclear features that raise concern for papillary carcinoma. AUS carries approximately 10-30% malignancy risk and typically requires repeat FNA, molecular testing, or surgical evaluation. The category was refined in the 2017 Bethesda update to reduce diagnostic ambiguity.

Usage

Usage note: Commonly abbreviated as AUS; part of standardized Bethesda terminology.

In Context

  • "The cytology showed atypia of undetermined significance, prompting repeat FNA in three months." — Pathology report
  • "Molecular testing was ordered for the AUS nodule to refine risk stratification." — Endocrinology consultation

Also known as

AUS Bethesda Category III

Contrasted with

benign malignant

Don't confuse with

suspicious for malignancy follicular lesion

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON